Tag: Tidepool
Sequel Med Tech’s twiist now available nationwide
March 10, 2026HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced broad national availability of its twist Automated Insulin Delivery (AID) System powered by Tidepool, following clearance by the U.S. Food and Drug Administration in 2024 and a subsequent controlled launch. “With twiist now accessible to more people than ever before, we’ve reached a meaningful milestone for Sequel and for people living with type 1 diabetes,” said Sequel CEO and Co-Founder Alan Lotvin, MD. “twiist was built...
Tidepool, ŌURA partner to scale diabetes data
November 10, 2025HME News Staff
PALO ALTO, Calif. - Tidepool, a provider of diabetes software, has announced a strategic collaboration with ŌURA to support a groundbreaking dataset that they intend to make available for diabetes research. With participant consent and authorized disclosure, Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs)...